Improving healthcare products and services by testing in real world settings

Let’s improve healthcare products and services by testing in real world settings. What are the true and urgent needs of SME’s working within healthcare?

We call on your help, experience and expertise to validate and further improve our conclusions by answering the short questionnaire found here: https://www.survey-xact.dk/LinkCollector?key=WX4AW3UPL216. The questionnaire is online and open for responses until January 27th.

For the past three years, the European Union Regional Development Fund has co-financed the project, ProVaHealth under the Baltic Sea Region program.

The project has worked towards uncovering and removing barriers for the slow market uptake of innovations, and facilitation of market access for small and medium sized companies working within health. In that regard, we have executed 14 cross-border test collaborations between Living Labs and SMEs, with the aim of identifying best practices and important barriers for transnational collaboration.

Now we seek to validate these results in an effort to target the true and urgent needs of SME's working within healthcare.

We’ve found several areas to which we now seek broader validation, so that we can address the true and urgent needs of SME’s working within healthcare.

As an appreciation of your contribution, we offer to mention you or the organisation you represent as an expert in the report, and send you a digital copy when it is complete. We will only use your comments in the report with your specific consent.

About ProVaHealth

In 2017 the European Union Regional Development Fund has co-financed the project, ProVaHealth with 2,3 million EUR under the Baltic Sea Region program. ProVaHealth is a collaboration between 16 primary partners from eight different Baltic Sea countries.

The purpose of the project is to build an international network of specialised partners who support healthcare-related start-up’s with qualification, testing and validation of products and services in real life settings and assisting in early market access.

200.000 EUR of the total funding was allocated to the Health Innovation Centre of Southern Denmark who has participated in coordinating and executing the project tasks. In addition to this, The Health Innovation Centre of Southern Denmark has been the primary coordinator of establishing and executing 14 international tests between the 14 Living Labs in the project and 14 SME’s from across the Baltic Sea Region. 

 

 






Contact
SDSI
Special advisor
Emil Kjærsgaard Nielsen
+45 4019 6903
ekn@rsyd.dk